This chemical is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug compounds. It serves as a key intermediate in the production of active pharmaceutical ingredients (APIs) that target neurological and psychiatric disorders. Its structure is advantageous for designing molecules with potential therapeutic effects on the central nervous system, such as anxiolytics or anticonvulsants. Additionally, it is employed in medicinal chemistry for the exploration of new triazole and diazepine derivatives, which are known for their biological activity and therapeutic potential.